Treatment for premature ejaculation to hit market

Published: 2009-05-11 06:57:00

Updated: 2009-05-11 06:57:00

Korean men with premature ejaculation will be able to prevent premature ejaculation, a distressing sexual dysfunction that can be present from the first sexual encounter or can develop later in life, within this year.

Janssen Korea, the subsidiary of the U.S. Pharmaceutical firm Johnson & John...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK